12 Cases of CVST Reported for Ad26.COV2.S Vaccine in the U.S.

TUESDAY, May 4, 2021 -- Twelve cases of cerebral venous sinus thrombosis (CVST) with thrombocytopenia have been reported following use of the Ad26.COV2.S COVID-19 vaccine (Janssen/Johnson& Johnson), which uses a human adenoviral vector,...
Source: Drugs.com - Pharma News - Category: Pharmaceuticals Source Type: news